BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31245158)

  • 1. History of Esophagogastric Junction Cancer Treatment and Current Surgical Management in Western Countries.
    Berlth F; Hoelscher AH
    J Gastric Cancer; 2019 Jun; 19(2):139-147. PubMed ID: 31245158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction.
    Hosoda K; Yamashita K; Katada N; Watanabe M
    Gen Thorac Cardiovasc Surg; 2015 Oct; 63(10):549-56. PubMed ID: 26232357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dilemmas in definition and classification of adenocarcinoma of esophagogastric junction: from history to current status].
    Chen L; Liu FL
    Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):813-818. PubMed ID: 36058706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimally invasive surgery in adenocarcinoma of esophagogastric junction].
    Zang L; Li S; Zheng M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):875-880. PubMed ID: 30136267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
    Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy].
    Yamashita H; Seto Y
    Kyobu Geka; 2017 Jan; 70(1):72-79. PubMed ID: 28174399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Western strategy for EGJ carcinoma.
    Giacopuzzi S; Bencivenga M; Weindelmayer J; Verlato G; de Manzoni G
    Gastric Cancer; 2017 Mar; 20(Suppl 1):60-68. PubMed ID: 28039533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.
    Cai MZ; Lv CB; Cai LS; Chen QX
    Medicine (Baltimore); 2019 Dec; 98(51):e18451. PubMed ID: 31861019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective.
    Goetze TO; Al-Batran SE; Berlth F; Hoelscher AH
    J Gastric Cancer; 2019 Jun; 19(2):148-156. PubMed ID: 31245159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends.
    Kumamoto T; Kurahashi Y; Niwa H; Nakanishi Y; Okumura K; Ozawa R; Ishida Y; Shinohara H
    Surg Today; 2020 Aug; 50(8):809-814. PubMed ID: 31278583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of esophagogastric junction tumors.
    von Rahden BH; Stein HJ; Siewert JR
    World J Gastroenterol; 2006 Nov; 12(41):6608-13. PubMed ID: 17075972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of esophago-gastric junction adenocarcinoma.
    de Manzoni G; Zanoni A; Giacopuzzi S
    Ann Ital Chir; 2012; 83(3):208-14. PubMed ID: 22595732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.